CLINICAL_TRIALS
trial_result
· 2014-07-09
Clinical Trial Update: Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia [Phase 2]
Summary
Phase 2 study of temozolomide in patients with poor-risk or refractory acute myeloid leukemia has been completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bruno C. Medeiros | Conditions: Leukemia, Myeloid | Phase 2 | Status: COMPLETED | Results posted: 2014-07-09